Spectris - SXS Share Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Spectris in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SXS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SXS, but not buy additional shares or sell existing shares.
View SXS analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 12-month price targets for Spectris' shares. Their SXS share price forecasts range from GBX 3,485 to GBX 3,870. On average, they predict the company's stock price to reach GBX 3,668.33 in the next year. This suggests a possible upside of 0.5% from the stock's current price.
View analysts price targets for SXS or view top-rated stocks among Wall Street analysts.

Spectris' stock was trading at GBX 3,002 at the beginning of 2023. Since then, SXS stock has increased by 21.6% and is now trading at GBX 3,649.21.
View the best growth stocks for 2023 here.

Spectris plc (LON:SXS) posted its quarterly earnings data on Thursday, February, 20th. The company reported $168.00 EPS for the quarter, topping the consensus estimate of $163.20 by $4.80. Spectris had a trailing twelve-month return on equity of 8.51% and a net margin of 30.25%.

Spectris declared a dividend on Thursday, February 23rd. Stockholders of record on Thursday, May 18th will be paid a dividend of GBX 51.30 per share on Friday, June 30th. This represents a yield of 1.63%. The ex-dividend date is Thursday, May 18th. This is a positive change from the stock's previous dividend of GBX 24.10. The official announcement can be seen at this link.
Read our dividend analysis for SXS.

Spectris (LON:SXS) pays an annual dividend of GBX 75 per share and currently has a dividend yield of 2.16%. The dividend payout ratio is 7,075.47%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for SXS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Spectris investors own include Eiger BioPharmaceuticals (EIGR), Tesla (TSLA), AbbVie (ABBV), Anglo American (AAL), AK Steel (AKS), AltaGas (ALA), Applied Materials (AMAT), Advanced Micro Devices (AMD), ASOS (ASC) and AstraZeneca (AZN).

Spectris trades on the London Stock Exchange (LON) under the ticker symbol "SXS."

Shares of SXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of SXS stock can currently be purchased for approximately GBX 3,649.21.

Spectris (LON:SXS) has a market capitalization of £3.82 billion and generates £1.33 billion in revenue each year. The company earns £114.80 million in net income (profit) each year or GBX 1.06 on an earnings per share basis.

The company employs 7,788 workers across the globe.

Spectris' mailing address is Heritage House, Church Road, EGHAM, TW20 9QD, United Kingdom. The official website for the company is www.spectris.com. The company can be reached via phone at +44-1784-470470.